Ferumoxytol-enhanced MRI of Cerebrovascular Diseases

Go Back to All Clinical Trials

Ferumoxytol-enhanced MRI of Cerebrovascular Diseases

Brief description of study

The purpose of this research study is to assess new magnetic resonance imaging methods and a new contrast agent for the evaluation of cerebrovascular diseases. It is hoped that these techniques will enable researchers and clinicians to better detect cerebrovascular diseases. The images collected of the brains of patients with cerebrovascular diseases will be compared to the images from healthy volunteers to assess the technique and agent's sensitivity.

Clinical Study Identifier: s15-00296

Principal Investigator: Yulin Ge.

Other Investigators: Elizabeth Pippa Storey, Li Jiang, Marco Muccio, Ilya Kister, Yongxian Qian, Thomas M Wisniewski.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies